l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurihara, S; Monma, S; Oikawa, T; Shimada, K; Sugimura, Y; Tamaki, K; Tanzawa, K | 1 |
| Akiyama, T; Nakajima, M; Okuyama, A | 1 |
1 review(s) available for l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine and Fibrosarcoma
| Article | Year |
|---|---|
[CDK and MMP inhibitors].
Topics: 4-Butyrolactone; Animals; Antineoplastic Agents; Colonic Neoplasms; Cyclin-Dependent Kinases; Dipeptides; Doxorubicin; Enzyme Inhibitors; Fibrosarcoma; Humans; Metalloendopeptidases; Mice; Mice, Nude; Protease Inhibitors; Succinates | 1997 |
1 other study(ies) available for l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine and Fibrosarcoma
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of gelatinase inhibitors derived from matlystatins.
Topics: Acetylcysteine; Chromatography, High Pressure Liquid; Dipeptides; Fibrosarcoma; Gelatinases; Humans; Magnetic Resonance Spectroscopy; Metalloendopeptidases; Protease Inhibitors; Pyridazines; Structure-Activity Relationship; Substrate Specificity; Succinates; Thermolysin; Tumor Cells, Cultured | 1995 |